BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14654926)

  • 21. Formal geriatric assessment, An imperative for the older person with cancer.
    Roche RJ; Forman WB; Rhyne RL
    Cancer Pract; 1997; 5(2):81-6. PubMed ID: 9110643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
    Orsitto G; Cascavilla L; Franceschi M; Aloia RM; Greco A; Paris F; Seripa D; Pilotto A
    J Nutr Health Aging; 2005; 9(3):194-8. PubMed ID: 15864400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients.
    Cederholm T; Persson M; Andersson P; Stenvinkel P; Nordfors L; Madden J; Vedin I; Wretlind B; Grimble RF; Palmblad J
    J Intern Med; 2007 Aug; 262(2):215-23. PubMed ID: 17645589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease.
    Koutouzis M; Rallidis LS; Peros G; Nomikos A; Tzavara V; Barbatis C; Andrikopoulos V; Vassiliou J; Kyriakides ZS
    Acta Neurol Scand; 2009 Feb; 119(2):119-25. PubMed ID: 18638042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.
    Luciani A; Ascione G; Bertuzzi C; Marussi D; Codecà C; Di Maria G; Caldiera SE; Floriani I; Zonato S; Ferrari D; Foa P
    J Clin Oncol; 2010 Apr; 28(12):2046-50. PubMed ID: 20308657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.
    Park MC; Lee SW; Choi ST; Park YB; Lee SK
    Scand J Rheumatol; 2007; 36(2):101-6. PubMed ID: 17476615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
    Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
    Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
    Mohile SG; Bylow K; Dale W; Dignam J; Martin K; Petrylak DP; Stadler WM; Rodin M
    Cancer; 2007 Feb; 109(4):802-10. PubMed ID: 17219443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
    In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
    Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
    Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.
    Liao WC; Lin JT; Wu CY; Huang SP; Lin MT; Wu AS; Huang YJ; Wu MS
    Clin Cancer Res; 2008 Jan; 14(2):428-34. PubMed ID: 18198221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
    Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
    Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
    Kozłowski L; Zakrzewska I; Tokajuk P; Wojtukiewicz MZ
    Rocz Akad Med Bialymst; 2003; 48():82-4. PubMed ID: 14737948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.